| Hohlfeld, Jens |
NCT04231214: Effects of Spiolto® Respimat® (Tiotropium/Olodaterol) on Cardiac Function in Hyperinflated COPD Subjects |
|
|
| Completed | 4 | 32 | Europe | Olodaterol-Tiotropium | Fraunhofer-Institute of Toxicology and Experimental Medicine, Boehringer Ingelheim | Chronic Obstructive Pulmonary Disease | 04/23 | 04/23 | | |
NCT05351671: A Clinical Study to Determine the Safety, Tolerability and Effect of RLS-0071 Doses When Given to Healthy Adults After Inhaling LPS |
|
|
| Completed | 1b | 30 | Europe | RLS-0071 (10 mg/kg intravenously every 8 hours for total of 3 doses), RLS-0071 (loading dose of 120 mg/kg followed by 40 mg/kg every 8 hours for 2 additional doses), Placebo (saline dosed every 8 hours for a total of 3 doses) | ReAlta Life Sciences, Inc., FGK Clinical Research GmbH | Healthy | 09/22 | 09/22 | | |
NCT05516316: Clinical Trial Comparing the Pharmacological Effects of EP395 With Placebo in Healthy Adults |
|
|
| Completed | 1 | 49 | Europe | EP395, Placebo | EpiEndo Pharmaceuticals, FGK Clinical Research GmbH | Chronic Obstructive Pulmonary Disease, COPD | 06/23 | 06/23 | | |
NCT05226390: Safety, Reactogenicity and Immunogenicity of a Novel MVA-SARS-2-ST Vaccine Candidate |
|
|
| Terminated | 1 | 23 | Europe | MVA-SARS-2-ST | Hannover Medical School, German Center for Infection Research, IDT Biologika, Universitätsklinikum Hamburg-Eppendorf | COVID-19 Vaccines | 11/23 | 11/23 | | |
NCT06486662: A Clinical Study Investigating OM-85-IN Safety and Tolerability in Healthy Volunteers and Mild Allergic Asthma Patients |
|
|
| Recruiting | 1 | 41 | Europe | OM-85-IN, Placebo | OM Pharma SA | Allergic Asthma | 02/25 | 02/25 | | |
AMIR-21, NCT06752122: A Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of RCS-21 in Healthy Volunteers |
|
|
| Not yet recruiting | 1 | 48 | Europe | Placebo (in SAD), 0.9% saline solution, RCS-21 (in SAD), Placebo (MAD), RCS-21 (in MAD) | RNATICS GmbH, LungenClinic Grosshansdorf | Healthy Volunteers, Safety, Tolerability, Pharmacokinetics | 01/26 | 03/26 | | |
NCT06677918: Clinical Trial Investigating the Effects of EP395 Following an Inhaled Endotoxin Challenge in Healthy Adults |
|
|
| Not yet recruiting | 1 | 65 | Europe | EP395, Placebo | EpiEndo Pharmaceuticals, FGK Clinical Research GmbH | Healthy Volunteer | 06/26 | 06/26 | | |
NCT04775394: Activation of Apoptosis-related Receptors on Alveolar Macrophages |
|
|
| Completed | N/A | 28 | Europe | Bronchoscopy | Prof. Dr. Jens Hohlfeld | Chronic Obstructive Pulmonary Disease | 07/23 | 07/23 | | |
UBAMBI, NCT05346718: Threshold Concentrations for Ragweed and Birch Pollen in Seasonal Allergic Rhinitis |
|
|
| Recruiting | N/A | 18 | Europe | Ragweed pollen, birch pollen, clean air (placebo) | Fraunhofer-Institute of Toxicology and Experimental Medicine | Allergic Rhinitis, Seasonal Allergic Rhinitis, Ragweed Allergy, Birch Pollen Allergy | 12/24 | 12/24 | | |
NCT06317909: Development of a Novel Non-invasive Inflammometry Following Allergen Challenge in Patients with Mild Allergic Asthma |
|
|
| Recruiting | N/A | 15 | Europe | allergen challenge | Fraunhofer-Institute of Toxicology and Experimental Medicine | Mild Allergic Asthma | 09/25 | 09/25 | | |
